Article Text

other Versions

PDF
Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic therapy. A randomised controlled trial
  1. Jean-Marc Dumonceau (jmdumonceau{at}hotmail.com)
  1. University Hospital of Geneva, Switzerland
    1. Guido Costamagna (g.costamagna{at}eetc.it)
    1. Università Cattolica del Sacro Cuore, Italy
      1. Andrea Tringali (andreatringali{at}hotmail.com)
      1. Università Cattolica del Sacro Cuore, Italy
        1. Kouroche Vahedi
        1. Erasmus University Hospital, Netherlands
          1. Myriam Delhaye (mydelhay{at}ulb.ac.be)
          1. Erasmus University Hospital, Netherlands
            1. Axel Hittelet
            1. Erasmus University Hospital, Netherlands
              1. Gianluca Spera
              1. Università Cattolica del Sacro Cuore, Italy
                1. Emiliano Giostra (emiliano.giostra{at}hcuge.ch)
                1. University Hospital of Geneva, Switzerland
                  1. Massimiliano Mutignani
                  1. Università Cattolica del Sacro Cuore, Italy
                    1. Viviane De Maertelaer (vdemaert{at}ulb.ac.be)
                    1. Free University of Brussels, Belgium
                      1. Jacques Deviere (jdeviere{at}ulb.ac.be)
                      1. Erasmus University Hospital, Netherlands

                        Abstract

                        Background: In chronic pancreatitis (CP), obstruction of the main pancreatic duct (MPD) may participate in the pathogenesis of pain. Pilot studies suggest that extracorporeal shock wave lithotripsy (ESWL) alone relieves pain in calcified CP.

                        Aims: We compared ESWL alone with ESWL plus endoscopic drainage of the MPD for the treatment of pain in CP.

                        Subjects: Patients with uncomplicated painful CP and calcification(s) obstructing the MPD.

                        Methods: Fifty-five patients were randomized to ESWL alone (n=26) or ESWL plus endoscopy (n=29).

                        Results: Two years after trial intervention, 10 (38%) and 13 (45%) patients of the ESWL alone and ESWL plus endoscopy group, respectively, had presented pain relapse (primary outcome) (odds ratio 0.77; 95% CI, 0.23, 2.57). In both groups there was a similar decrease after treatment in the MPD diameter (mean decrease, 1.7 mm; 95% CI, 0.9-2.6; P=0.0002), and in the number of pain attacks/year (mean decrease, 3.7; 95% CI, 2.6-4.9; P<0.0001). Treatment costs per patient were 3 times higher in the ESWL plus endoscopy compared to the ESWL alone group (P=0.001). The median delay between the onset of CP and persistent pain relief for both groups was 1.1 year (95% CI, 0.7-1.6), as compared to 4 years (95% CI, 3- 4) for the natural history of CP in a reference cohort (P<0.0001).

                        Conclusions: ESWL is a safe and effective first line therapy for selected patients with painful calcified CP. Adding systematic endoscopy on top of ESWL adds to the cost of patient care without improving outcome of pancreatic pain.

                        • calculi
                        • chronic pancreatitis
                        • endoscopy
                        • lithotripsy

                        Statistics from Altmetric.com

                        Request permissions

                        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                        Linked Articles

                        • Digest
                          Robin Spiller Emad El-Omar